Adverse Events Associated With Dabrafenib, Trametinib, and Their Combination Therapy: A Disproportionality Analysis of the FDA Adverse Event Reporting System ( FAERS ) Database

Ähnliche Einträge

• Adverse Event Assessment of Upadacitinib: A Pharmacovigilance Study Based on the FAERS Database
  von: Jiayu Yuan, et al.
  Veröffentlicht: (2024)
• A Real‐World Study on Adverse Reactions of Belimumab Based on the FDA Adverse Event Reporting System Database
  von: Le Hai, et al.
  Veröffentlicht: (2024)
• Aioli: Standardising Drugs in the FDA Adverse Event Reporting System ( FAERS ) to RxNorm and Anatomical Therapeutic Chemical ( ATC ) Codes
  von: Rowan E. Parry, et al.
  Veröffentlicht: (2025)
• A Real‐World Pharmacovigilance Study of FDA Adverse Event Reporting System Events for Obeticholic Acid
  von: Le Hai, et al.
  Veröffentlicht: (2025)
• Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events
  von: W. N. Kelly, et al.
  Veröffentlicht: (2024)